{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:36:44Z","timestamp":1775446604705,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"am","delay-in-days":411,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["NIH (1R01 NS078289)"],"award-info":[{"award-number":["NIH (1R01 NS078289)"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Center for Translational Science","award":["NIH (3UH3 TR000491-05S1)"],"award-info":[{"award-number":["NIH (3UH3 TR000491-05S1)"]}]},{"name":"Department of Defense Congressionally Director Research Program","award":["W81XWH-11-1-0240"],"award-info":[{"award-number":["W81XWH-11-1-0240"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["TSCRP (W81XWH-17-1-0151)"],"award-info":[{"award-number":["TSCRP (W81XWH-17-1-0151)"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Community\u2019s Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"EPISTOP","award":["602391"],"award-info":[{"award-number":["602391"]}]},{"DOI":"10.13039\/501100005632","name":"Polish National Center for Research and Development","doi-asserted-by":"crossref","award":["STATEGMED3\/306306\/4\/2016"],"award-info":[{"award-number":["STATEGMED3\/306306\/4\/2016"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 NS056872"],"award-info":[{"award-number":["R01 NS056872"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 NS079321"],"award-info":[{"award-number":["R01 NS079321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejpn.2018.06.007","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T22:37:12Z","timestamp":1530657432000},"page":"1066-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-7391","authenticated-orcid":false,"given":"Darcy A.","family":"Krueger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie K.","family":"Capal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-7351","authenticated-orcid":false,"given":"Kevin","family":"Ess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Tzadok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-3847","authenticated-orcid":false,"given":"Vinodh","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-8827","authenticated-orcid":false,"given":"Federico","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiusz","family":"Jozwiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petrus","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-2824","authenticated-orcid":false,"given":"Anna C.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mowat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Neal","family":"Franz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejpn.2018.06.007_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2018.06.007_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2013 baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001493","article-title":"Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the international tuberous sclerosis consensus group","volume":"3","author":"Hinton","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American thoracic Society\/Japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference 2012","volume":"49","author":"Roth","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2018.06.007_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1464-410X.2009.08649.x","article-title":"Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated","volume":"105","author":"Sooriakumaran","year":"2010","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.ejpn.2018.06.007_bib7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2018.06.007_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.ejpn.2018.06.007_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","article-title":"Renal angiomyolipomata","volume":"66","author":"Bissler","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ejpn.2018.06.007_bib10","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1159\/000320891","article-title":"Tuberous sclerosis complex renal disease","volume":"118","author":"Dixon","year":"2011","journal-title":"Nephron Exp Nephrol"},{"issue":"12","key":"10.1016\/j.ejpn.2018.06.007_bib11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol"},{"issue":"9869","key":"10.1016\/j.ejpn.2018.06.007_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejpn.2018.06.007_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ejpn.2018.06.007_bib14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejpn.2018.06.007_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1016\/j.ejpn.2018.06.007_bib16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"issue":"10056","key":"10.1016\/j.ejpn.2018.06.007_bib17","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ejpn.2018.06.007_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2018.06.007_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2017.06.076","article-title":"Everolimus for the treatment of tuberous sclerosis complex-related cardiac rhabdomyomas in pediatric patients","volume":"190","author":"Dahdah","year":"2017","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.ejpn.2018.06.007_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-4362.1998.00495.x","article-title":"Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance","volume":"37","author":"Jozwiak","year":"1998","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4040","article-title":"Presentation and diagnosis of tuberous sclerosis complex in infants","volume":"140","author":"Davis","year":"2017","journal-title":"Pediatrics"},{"issue":"9861","key":"10.1016\/j.ejpn.2018.06.007_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-Term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study","volume":"11","author":"Franz","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl. 3","key":"10.1016\/j.ejpn.2018.06.007_bib24","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1016\/S0012-3692(15)35466-0","article-title":"Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis","volume":"121","author":"McCormack","year":"2002","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ejpn.2018.06.007_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24523","article-title":"Everolimus for subependymal giant cell astrocytoma: 5-year final analysis","volume":"78","author":"Franz","year":"2015","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.ejpn.2018.06.007_bib27","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1212\/WNL.0000000000003400","article-title":"Long-term treatment of epilepsy with eveorlimus in tuberous sclerosis","volume":"87","author":"Krueger","year":"2016","journal-title":"Neurology"},{"issue":"9639","key":"10.1016\/j.ejpn.2018.06.007_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2018.06.007_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2016.01.027","article-title":"Safety of everolimus in patients younger than 3 Years of age: results from EXIST-1, a randomized, controlled clinical trial","volume":"172","author":"Jozwiak","year":"2016","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.ejpn.2018.06.007_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","article-title":"Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma","volume":"80","author":"Krueger","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2018.06.007_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40265-016-0552-9","article-title":"The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: evidence-based and expert opinions","volume":"76","author":"Curatolo","year":"2016","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejpn.2018.06.007_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00246-016-1528-y","article-title":"Accelerated cardiac rhabdomyoma regression with everolimus in infants with tuberous sclerosis complex","volume":"38","author":"Aw","year":"2017","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"10.1016\/j.ejpn.2018.06.007_bib33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1047951116000421","article-title":"Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex","volume":"26","author":"Colaneri","year":"2016","journal-title":"Cardiol Young"},{"issue":"1","key":"10.1016\/j.ejpn.2018.06.007_bib34","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1542\/peds.2011-3476","article-title":"Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma","volume":"130","author":"Demir","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejpn.2018.06.007_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/tropej\/fmu056","article-title":"Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus","volume":"61","author":"Dogan","year":"2015","journal-title":"J Trop Pediatr"},{"issue":"4","key":"10.1016\/j.ejpn.2018.06.007_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pediatrneurol.2015.01.004","article-title":"Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex","volume":"52","author":"Goyer","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2018.06.007_bib37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/uog.13434","article-title":"Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus","volume":"45","author":"Mlczoch","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejpn.2018.06.007_bib38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S1047951114002261","article-title":"Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia","volume":"25","author":"Oztunc","year":"2015","journal-title":"Cardiol Young"},{"issue":"9","key":"10.1016\/j.ejpn.2018.06.007_bib39","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ajmg.a.37148","article-title":"Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC)","volume":"167a","author":"Pollack","year":"2015","journal-title":"Am J Med Genet Part A"},{"issue":"9","key":"10.1016\/j.ejpn.2018.06.007_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/0883073813499969","article-title":"Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors","volume":"29","author":"Prato","year":"2014","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2018.06.007_bib41","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1542\/peds.2010-2910","article-title":"Regression of a cardiac rhabdomyoma in a patient receiving everolimus","volume":"127","author":"Tiberio","year":"2011","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ejpn.2018.06.007_bib42","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/echo.13015","article-title":"Oral everolimus for treatment of a giant left ventricular rhabdomyoma in a neonate-rapid tumor regression documented by real time 3D echocardiography","volume":"32","author":"Wagner","year":"2015","journal-title":"Echocardiography"},{"issue":"3","key":"10.1016\/j.ejpn.2018.06.007_bib43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0883073807309250","article-title":"Clinical presentation and diagnosis of tuberous sclerosis complex in infancy","volume":"23","author":"Datta","year":"2008","journal-title":"J Child Neurol"},{"issue":"Pt A","key":"10.1016\/j.ejpn.2018.06.007_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav E&B"},{"issue":"7","key":"10.1016\/j.ejpn.2018.06.007_bib45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.ejpn.2018.06.007_bib46","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1017\/S0033291715000264","article-title":"Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study","volume":"45","author":"Bolton","year":"2015","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.ejpn.2018.06.007_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpn.2009.03.003","article-title":"Early control of seizures improves long-term outcome in children with tuberous sclerosis complex","volume":"14","author":"Bombardieri","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2018.06.007_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0883073807309788","article-title":"Characterization of autism in young children with tuberous sclerosis complex","volume":"23","author":"Jeste","year":"2008","journal-title":"J Child Neurol"},{"issue":"8","key":"10.1016\/j.ejpn.2018.06.007_bib49","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1212\/WNL.0000000000003002","article-title":"Symptom profiles of autism spectrum disorder in tuberous sclerosis complex","volume":"87","author":"Jeste","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2018.06.007_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"J\u00f3\u017awiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"issue":"21","key":"10.1016\/j.ejpn.2018.06.007_bib51","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.ejpn.2018.06.007_bib52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379817319694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379817319694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:35:58Z","timestamp":1761071758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379817319694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1090379817319694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.06.007","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}